SCHEMBL5186756

SCHEMBL5186756

CCCCCOc1ccc(N2CCN(c3ccc(C(=O)O)cc3)CC2)cc1

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.73
TP53 P04637 1/20 0.73
PLA2G4B P0C869 7/20 0.71
RARB P10826 4/20 0.68
PLA2G4A P47712 1/20 0.64
THRA P10827 1/20 0.64
THRB P10828 1/20 0.64
MAPT P10636 3/20 0.61
HPGD P15428 1/20 0.61
TAAR1 Q96RJ0 1/20 0.61
HSD17B10 Q99714 1/20 0.61
ALDH1A1 P00352 1/20 0.59
HIF1A Q16665 1/20 0.59
KDM4E B2RXH2 1/20 0.57
LMNA P02545 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
HTT P42858 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7332274 0.99 TSHR (0.71) TSHRTP53PLA2G4BRARBPLA2G4A
SCHEMBL7339141 0.99 TSHR (0.76) TSHRTP53PLA2G4BRARBPLA2G4A
Hydrochloric Acid SCHEMBL6539254 0.97 TSHR (0.74) TSHRTP53PLA2G4BRARBPLA2G4A
Hydrochloric Acid SCHEMBL7334829 0.97 TSHR (0.74) TSHRTP53PLA2G4BRARBPLA2G4A
Hydrochloric Acid SCHEMBL7330237 0.97 TSHR (0.74) TSHRTP53PLA2G4BRARBPLA2G4A
Hydrochloric Acid SCHEMBL7339554 0.88 TSHR (0.60) TSHRTP53PLA2G4BRARBPLA2G4A
SCHEMBL6538491 0.87 TSHR (0.62) TSHRTP53PLA2G4BRARBPLA2G4A
SCHEMBL7331983 0.87 TSHR (0.59) TSHRTP53PLA2G4BRARBPLA2G4A
SCHEMBL7333300 0.87 TSHR (0.59) TSHRTP53PLA2G4BRARBPLA2G4A
SCHEMBL503727 0.87 TP53 (0.96) TSHRTP53PLA2G4BRARBPLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285619-B2 Echinocandin derivatives, their method of preparation and their application as anti-fungal agents AVENTIS PHARMA S.A. (FR) 2007-10-23 US disclosed
US-7160983-B2 Echinocandin derivatives, their method of preparation and their application as anti-fungal agents AVENTIS PHARMA S.A. (FR) 2007-01-09 US disclosed
US-20050267019-A1 Echinocandin derivatives, their method of preparation and their application as anti-fungal agents NOVEXEL (FR) 2005-12-01 US disclosed
US-20040072737-A1 1((-4-oxo- N2-(12-methyl-1-oxotetradecyl) L-ornithine) 4-(4-(4- hydroxyphenyl)-L-threonine)-5-L-serine-echinocandin B, and other derivatives AVENTIS PHARMA S.A. 2004-04-15 US disclosed
US-6677429-B1 FUNGICIDES SUCH AS 1-((S)-N2-(12-METHYL-1-OXOTETRADECYL)-4-(((3-PIPERIDINYL)OXY)IMINO)-L -ORNITHINE)4-((4-HYDROXYPHENYL)-L -THREONINE)-5-L-SERINE AND ISOMERS ADMINISTERING TO MAMMALS AS ANTIPROLIFERATIVE AGENTS FOR CANDIDA AVENTIS PHARMA S.A. (FR) 2004-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040072737-A1 1((-4-oxo- N2-(12-methyl-1-oxotetradecyl) L-ornithine) 4-(4-(4- hydroxyphenyl)-L-threonine)-5-L-serine-echinocandin B, and other derivatives ODC1, OAT, DPM1 TSHR 4684/4885TP53 1649/4885PLA2G4B 1254/4885
US-20050267019-A1 Echinocandin derivatives, their method of preparation and their application as anti-fungal agents ERG28, DPM1, CYP51A1 TSHR 4662/4885TP53 3425/4885PLA2G4B 3342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.